caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a reverse transcriptase inhibitor and belongs to the anti viral agent class of molecules, impacting hiv treatment and is characterized as anti viral. | Cc1cccc(C)c1Nc1c(-c2ccc(F)cc2F)nc2scc(-c3ccccc3)n12 | [
"anti viral",
"anti viral agent",
"reverse transcriptase inhibitor",
"hiv treatment"
] |
The molecule is a nutrient that affects breast cancer by impacting ulcerative colitis, atherosclerosis, and cervical cancer. | CCCCCc1oc(CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCCC)c(C)c1C | [
"Ulcerative colitis",
"Atherosclerosis",
"Cervical cancer",
"Breast cancer",
"nutrient"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and tangier disease. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Aging",
"Barth syndrome",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Apoptosis"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts aging and tangier disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Aging",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | [
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis, it impacts aging, and is smooth. The molecule is a food additive, surfactant, nutritional supplement that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, a proton trap for oxidative phosphorylation, and a energy source, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, energy storage, emulsifier, membrane stabilizer that impacts tangier disease. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C | [
"Aging",
"Smooth",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Barth syndrome",
"food additive",
"Non-alcoholic fatty liver disease",
"surfactant",
"Nutritional supplement",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Energy source",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Energy storage",
"Emulsifier",
"Membrane stabilizer",
"Tangier disease"
] |
It impacts diabetes mellitus, seizure, parkinson's disease, and breast cancer. It impacts stomach cancer, colorectal cancer, cardiovascular disease, and alzheimer's disease. | CCCCC/C=C\CC1OC1CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O | [
"Diabetes mellitus",
"Seizure",
"Parkinson's disease",
"Breast cancer",
"Stomach cancer",
"Colorectal cancer",
"Cardiovascular disease",
"Alzheimer's Disease"
] |
The molecule is anti proliferative. | Cc1nc(NN)c2ccccc2n1 | [
"anti proliferative"
] |
It influences both breast cancer and stomach cancer, as well as affecting seizure and parkinson's disease. It impacts diabetes mellitus, alzheimer's disease, cardiovascular disease, and colorectal cancer. | CC/C=C\C/C=C\C/C=C\C/C=C\C=C/C(O)C/C=C\CCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCC/C=C\CCCCCC | [
"Breast cancer",
"Seizure",
"Parkinson's disease",
"Stomach cancer",
"Diabetes mellitus",
"Alzheimer's Disease",
"Cardiovascular disease",
"Colorectal cancer"
] |
The molecule is a kinase inhibitor. | Clc1cnc2nc(-c3ccc(OCCN4CCOCC4)cc3)[nH]c2c1N1CCCC1 | [
"kinase inhibitor"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease and aging. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Cholesterol translocation",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Aging"
] |
The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, tangier disease, and diabetic heart disease. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Aging",
"Tangier disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure that impacts tangier disease and aging. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Barth syndrome",
"Diabetic heart disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, and barth syndrome. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)CC | [
"Aging",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Barth syndrome",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Aging",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, apoptosis, cholesterol translocation that impacts tangier disease and aging. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Cholesterol translocation",
"Tangier disease",
"Aging"
] |
The molecule is a renin inhibitor and belongs to the hypertension treatment class of molecules. | Cc1cccc(CN(C(=O)C2CNCCC2NC(=O)c2ccc(F)c(Cl)c2)C2CC2)c1C | [
"hypertension treatment",
"renin inhibitor"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging. The molecule is a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. | CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Aging",
"Apoptosis",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing mitochondrial structure"
] |
It has an effect on stomach cancer, and impacts breast cancer, parkinson's disease, and seizure. It impacts colorectal cancer, diabetes mellitus, alzheimer's disease, and cardiovascular disease. | CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@@H]1COP(=O)(O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](C/C=C/CCCC(=O)O1)[C@@H](O)C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@H]2O | [
"Breast cancer",
"Parkinson's disease",
"Seizure",
"Stomach cancer",
"Colorectal cancer",
"Diabetes mellitus",
"Alzheimer's Disease",
"Cardiovascular disease"
] |
The molecule is a membrane stabilizer, surfactant, nutrient, energy source, energy storage, emulsifier. | C=C1C(=O)OC2C3=C(C)C(=O)CC(O)C3(C)CCC12 | [
"Membrane stabilizer",
"surfactant",
"nutrient",
"Energy source",
"Energy storage",
"Emulsifier"
] |
The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, aging, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Barth syndrome",
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase"
] |
The electroluminescent class molecule influences low voltage and is organic electroluminescent. | c1ccc(C2(c3ccc(N(c4cccc(-c5ccc6sc7ccccc7c6c5)c4)c4cccc(-c5ccc6sc7ccccc7c6c5)c4)cc3)c3ccccc3-c3ccccc32)cc1 | [
"organic electroluminescent",
"low voltage",
"electroluminescent"
] |
It has an effect on stomach cancer, and impacts cardiovascular disease, diabetes mellitus, and parkinson's disease. It has an effect on colorectal cancer, and impacts alzheimer's disease, seizure, and breast cancer. | CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCCC | [
"Cardiovascular disease",
"Diabetes mellitus",
"Parkinson's disease",
"Stomach cancer",
"Alzheimer's Disease",
"Seizure",
"Breast cancer",
"Colorectal cancer"
] |
The molecule is a membrane stabilizer and a food additive, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a stabilizing mitochondrial structure, surfactant, cholesterol translocation, apoptosis that impacts barth syndrome. The molecule is a energy source, a stabilizing cytochrome oxidase, and a proton trap for oxidative phosphorylation, and it impacts aging. The molecule is a emulsifier, energy storage, nutritional supplement that impacts tangier disease and diabetic heart disease. | CCC(C)CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Smooth",
"Membrane stabilizer",
"food additive",
"Stabilizing mitochondrial structure",
"surfactant",
"Cholesterol translocation",
"Barth syndrome",
"Apoptosis",
"Energy source",
"Stabilizing cytochrome oxidase",
"Aging",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Emulsifier",
"Energy storage",
"Nutritional supplement",
"Diabetic heart disease"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Aging",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Apoptosis",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
The molecule is anti emetic. | COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCNC(=O)C2CN3CCC2CC3)CC1OC | [
"anti emetic"
] |
The molecule is a obesity treatment member of the 5ht2c receptor agonist class. | COc1cc(OCCN2CCOc3cc4c(c(C5CC5)c32)CCN(C(=O)OC(C)(C)C)CC4)c(F)cc1C#N | [
"5ht2c receptor agonist",
"obesity treatment"
] |
The molecule is a hsp90 inhibitor that impacts cancer treatment. | CN1CCC(NC(=O)Nc2cc(-c3c(O)cc(O)cc3Oc3ccc(N=O)cc3)on2)CC1 | [
"cancer treatment",
"hsp90 inhibitor"
] |
The molecule is a energy source that impacts cardiovascular disease, inflammatory bowel disease, and renal cell carcinoma. It has an effect on breast cancer, and impacts celiac disease, diabetes mellitus type 2, and heart failure. | CCCCC(O)CCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | [
"Cardiovascular disease",
"Inflammatory bowel disease",
"Energy source",
"Renal cell carcinoma",
"Celiac disease",
"Breast cancer",
"Diabetes mellitus type 2",
"Heart failure"
] |
It impacts asthma treatment. | O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C1COc2c(CCNCCN(C(=O)CCNCCc3cc(F)cc(Cl)c3)C3CCCCC3)ccc(O)c2N1 | [
"asthma treatment"
] |
The molecule is a mek inhibitor, tyrosine kinase inhibitor, leukotriene inhibitor, belonging to the electroluminescent class of molecules, impacts inflammation treatment, and is cancer treatment. | CCc1cnc(C)c(C)c1C | [
"inflammation treatment",
"electroluminescent",
"cancer treatment",
"mek inhibitor",
"tyrosine kinase inhibitor",
"leukotriene inhibitor"
] |
The molecule is a nutrient and thyroxine treatment, and it impacts metabolic syndrome. The molecule is a fat storage that impacts pancreatitis, cardiovascular disease, and atherosclerosis. | CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC)OCCCCCCCCCCCCCCCCCC | [
"Thyroxine treatment",
"nutrient",
"Metabolic syndrome",
"Pancreatitis",
"Cardiovascular disease",
"Atherosclerosis",
"Fat storage"
] |
The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, tangier disease, and diabetic heart disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Aging",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Tangier disease",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts aging, tangier disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome",
"Aging",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
The molecule is a fat storage and a energy storage that impacts atherosclerosis, obesity, metabolic syndrome, and pancreatitis. The molecule is a inflammatory and thyroxine treatment, and it impacts cardiovascular disease. The molecule is a energy source, a membrane stabilizer, and a nutrient, and it impacts cancer. | CCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCC | [
"Atherosclerosis",
"Obesity",
"Fat storage",
"Metabolic syndrome",
"Energy storage",
"Pancreatitis",
"Thyroxine treatment",
"Cardiovascular disease",
"inflammatory",
"Energy source",
"Membrane stabilizer",
"nutrient",
"Cancer"
] |
The molecule is a diabetes treatment and belongs to both the anti bacterial and obesity treatment classes of molecules. | NCCCOc1ccc(S)cc1 | [
"diabetes treatment",
"anti bacterial",
"obesity treatment"
] |
The molecule is a anti viral. | CCCCCONC(C)C(=O)OP(=O)(OCC1C=CC(n2cnc3c(NC4CC4)nc(N)nc32)C1)Oc1ccccc1 | [
"anti viral"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a apoptosis that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCC | [
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Aging",
"Cholesterol translocation",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Barth syndrome"
] |
The molecule is a nutrient, emulsifier, energy source, surfactant, membrane stabilizer, energy storage. | C=CC(C)(CC/C=C(\C)CCC=C(C)C)OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O | [
"nutrient",
"Emulsifier",
"Energy source",
"surfactant",
"Membrane stabilizer",
"Energy storage"
] |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease and aging. The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Aging",
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Tangier disease"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts barth syndrome, non-alcoholic fatty liver disease, aging, and tangier disease. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Aging",
"Tangier disease"
] |
The molecule is a membrane stabilizer, energy source, nutrient that impacts atherosclerosis, metabolic syndrome, and obesity. The molecule is a energy storage that impacts both cancer and pancreatitis. The molecule is a fat storage, a inflammatory, and a thyroxine treatment, and it impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"Atherosclerosis",
"Membrane stabilizer",
"Metabolic syndrome",
"Energy source",
"nutrient",
"Obesity",
"Energy storage",
"Cancer",
"Pancreatitis",
"Fat storage",
"inflammatory",
"Thyroxine treatment",
"Cardiovascular disease"
] |
The molecule is a pi3k inhibitor. | CC(Nc1nc(N)nc(N)c1C#N)c1nc2cccc(F)c2c(=O)n1-c1cccc(CC(F)F)c1 | [
"pi3k inhibitor"
] |
The molecule is a surfactant, a stabilizing cytochrome oxidase, and a apoptosis, and it impacts diabetic heart disease. The molecule is a food additive, a proton trap for oxidative phosphorylation, and a energy storage, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a nutritional supplement, a cholesterol translocation, and a stabilizing mitochondrial structure, and it impacts aging. The molecule is a energy source, emulsifier, membrane stabilizer that impacts barth syndrome and tangier disease. | CCC(C)CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"surfactant",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"food additive",
"Proton trap for oxidative phosphorylation",
"Smooth",
"Energy storage",
"Nutritional supplement",
"Cholesterol translocation",
"Aging",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Energy source",
"Emulsifier",
"Membrane stabilizer"
] |
The molecule is a fat storage that impacts both cardiovascular disease and atherosclerosis. The molecule is a nutrient and thyroxine treatment, impacting both pancreatitis and metabolic syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cardiovascular disease",
"Fat storage",
"Atherosclerosis",
"Thyroxine treatment",
"Pancreatitis",
"nutrient",
"Metabolic syndrome"
] |
The molecule is a nutrient that affects cervical cancer by impacting ulcerative colitis, breast cancer, and atherosclerosis. | CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCc1oc(CCC)c(C)c1C)[C@@H](O)CCCC(=O)O | [
"Ulcerative colitis",
"Cervical cancer",
"nutrient",
"Breast cancer",
"Atherosclerosis"
] |
The molecule is a nutrient. | CCCCC/C=C\C=C/[C@@H](O)C/C=C\C/C=C/CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCCCCCCCCCC | [
"nutrient"
] |
The molecule is a membrane stabilizer, energy source, fat storage that impacts cancer, pancreatitis, and obesity. The molecule is a nutrient and inflammatory, and it impacts metabolic syndrome. The molecule is a energy storage and thyroxine treatment, impacting both cardiovascular disease and atherosclerosis. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)CC | [
"Cancer",
"Membrane stabilizer",
"Energy source",
"Pancreatitis",
"Fat storage",
"Obesity",
"Metabolic syndrome",
"nutrient",
"inflammatory",
"Thyroxine treatment",
"Energy storage",
"Cardiovascular disease",
"Atherosclerosis"
] |
The molecule is a flavoring agent, a emulsifier, and pungent. The molecule is a surfactant and a energy source, as well as diffusive and alliaceous. The molecule is a membrane stabilizer, a nutrient, and chemical. The molecule is a energy storage, sweet, rum, and caramel. | O=C(OC1COC(=O)c2cc(O)c(O)c(O)c2-c2c(cc(O)c(O)c2O)C(=O)OC1C1OC(=O)c2cc(O)c(O)c(O)c2-c2c(O)c(O)c(O)c3c2C(=O)OC1C3c1c(O)cc(O)c2c1OC(c1cc(O)c(O)c(O)c1)C(O)C2)c1cc(O)c(O)c(O)c1 | [
"Flavoring agent",
"Emulsifier",
"pungent",
"diffusive",
"surfactant",
"Energy source",
"alliaceous",
"Membrane stabilizer",
"chemical",
"nutrient",
"Energy storage",
"sweet",
"rum",
"caramel"
] |
The molecule is a inflammatory treatment. | O=C(c1ccc(B(O)O)cc1)N1CCC(F)C1 | [
"inflammatory treatment"
] |
The molecule is a anti hiv, a angiogenesis inhibitor, and a anti cancer. | Cc1nc2cc(C3=CCC4C3(C)CCC3(Cl)CC5C(O)C(O)C(N(C)C)CC56CCC43O6)ccc2o1 | [
"anti hiv",
"angiogenesis inhibitor",
"anti cancer"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Diabetic heart disease",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing mitochondrial structure",
"Apoptosis"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Aging",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC | [
"Tangier disease",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Aging",
"Barth syndrome",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a nutrient, energy source, emulsifier, surfactant, energy storage, membrane stabilizer. | Cc1cc(N)c2ccccc2c1O | [
"nutrient",
"Energy source",
"Emulsifier",
"surfactant",
"Energy storage",
"Membrane stabilizer"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, apoptosis that impacts tangier disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Apoptosis",
"Barth syndrome"
] |
The molecule is balsam, powdery, and cinnamic. The molecule is sweet, green, spicy, and hyacinth. | CCCCCCCCCCCCCCCCCCCCCCCCCCCC=O | [
"balsam",
"powdery",
"cinnamic",
"sweet",
"green",
"spicy",
"hyacinth"
] |
The molecule is a energy storage, fat storage, energy source, inflammatory that belongs to the thyroxine treatment class of molecules and impacts cardiovascular disease. The molecule is a nutrient that impacts both obesity and pancreatitis. The molecule is a membrane stabilizer that affects cancer by impacting both atherosclerosis and metabolic syndrome. | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC | [
"Energy storage",
"Fat storage",
"Energy source",
"inflammatory",
"Thyroxine treatment",
"Cardiovascular disease",
"Obesity",
"Pancreatitis",
"nutrient",
"Atherosclerosis",
"Cancer",
"Metabolic syndrome",
"Membrane stabilizer"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Diabetic heart disease",
"Cholesterol translocation"
] |
The molecule is a cgrp receptor antagonist and belongs to the migraine treatment class of molecules. | CC(C)(C)OC(=O)N1CC=C(c2cc(Cl)cc(-c3nnc(CC(=O)N4CCC(N5CCc6ccccc6NC5=O)CC4)o3)c2)CC1 | [
"migraine treatment",
"cgrp receptor antagonist"
] |
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts diabetic heart disease and tangier disease. | CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Aging",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Diabetic heart disease",
"Cholesterol translocation",
"Tangier disease"
] |
It belongs to the anti obesity class of molecules. | CCCOC(Cc1ccc(OCCn2ncc3ccccc3c2=O)cc1)C(=O)OCC | [
"anti obesity"
] |
The molecule is a energy source, nutrient, inflammatory that impacts thyroxine treatment, metabolic syndrome, and cardiovascular disease. The molecule is a energy storage that impacts both pancreatitis and atherosclerosis. The molecule is a membrane stabilizer and a fat storage, impacting both cancer and obesity. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC | [
"Thyroxine treatment",
"Energy source",
"Metabolic syndrome",
"Cardiovascular disease",
"nutrient",
"inflammatory",
"Pancreatitis",
"Atherosclerosis",
"Energy storage",
"Membrane stabilizer",
"Fat storage",
"Cancer",
"Obesity"
] |
The molecule is a food and nutrition and a nutrient, belonging to the pharmaceutical, anti microbial agent, and drug classes of molecules. | O=c1cc(CO)occ1O | [
"Food and nutrition",
"Pharmaceutical",
"anti microbial agent",
"Drug",
"nutrient"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts barth syndrome and aging. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Aging",
"Apoptosis"
] |
It belongs to the anti inflammatory class of molecules. | CCOC(=O)Cc1cc(C(F)(F)F)c(C(=O)c2ccc(C)cc2)n1C | [
"anti inflammatory"
] |
The molecule is a energy source and inflammatory, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome, cardiovascular disease, and cancer. The molecule is a membrane stabilizer and energy storage, and it impacts pancreatitis. The molecule is a nutrient and a fat storage, impacting both atherosclerosis and obesity. | CCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCC | [
"Metabolic syndrome",
"Thyroxine treatment",
"Energy source",
"Cardiovascular disease",
"Cancer",
"inflammatory",
"Membrane stabilizer",
"Energy storage",
"Pancreatitis",
"nutrient",
"Atherosclerosis",
"Obesity",
"Fat storage"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts aging and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Tangier disease",
"Cholesterol translocation",
"Barth syndrome",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a energy source, nutrient, nutritional supplement that impacts parkinson's disease, non-alcoholic fatty liver disease, and diabetes mellitus type 2. The molecule is a energy storage, a surfactant, and smooth. The molecule is a membrane stabilizer, a food additive, and a emulsifier, and it impacts alzheimer's disease. | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCCN | [
"Energy source",
"nutrient",
"Nutritional supplement",
"Parkinson's disease",
"Non-alcoholic fatty liver disease",
"Diabetes mellitus type 2",
"Energy storage",
"surfactant",
"Smooth",
"Membrane stabilizer",
"food additive",
"Emulsifier",
"Alzheimer's Disease"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts tangier disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Tangier disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Apoptosis"
] |
The molecule is cancer treatment. | COc1ncccc1-c1ccc(O)c(-c2nc3ccc(C(=O)NCc4ccc5c(c4)n(C)c(=O)n5C)cc3[nH]2)c1 | [
"cancer treatment"
] |
The molecule is a trace element, human metabolite, cardioprotective, vasodilator agent. The molecule is a hypotensive and is both anxiolytic and belongs to the anti fatigue and angiotensin receptor blocker classes of molecules. The molecule is a anti stroke and angiotensin receptor antagonist, belonging to the beta-adrenergic antagonist class of molecules, and is diuretic. The molecule is a macronutrient, a anti spasmodic, a cardiotoxic agent, and anti arrhythmic. | [K+] | [
"Trace element",
"human metabolite",
"cardioprotective",
"vasodilator agent",
"anti fatigue",
"hypotensive",
"anxiolytic",
"angiotensin receptor blocker",
"diuretic",
"anti stroke",
"beta-adrenergic antagonist",
"angiotensin receptor antagonist",
"macronutrient",
"anti arrhythmic",
"anti spasmodic",
"cardiotoxic agent"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts aging and barth syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Cholesterol translocation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Aging",
"Stabilizing mitochondrial structure",
"Barth syndrome"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts tangier disease and aging. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure",
"Cholesterol translocation"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts barth syndrome and aging. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Aging",
"Cholesterol translocation",
"Diabetic heart disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Non-alcoholic fatty liver disease"
] |
The molecule is a kinase inhibitor. | NCC(C(=O)Nc1ccc2cnsc2c1)C1CCCCC1 | [
"kinase inhibitor"
] |
It belongs to the anti fungal class of molecules. | O=CCCNC(=O)CN(CC(=O)NCc1cccc(Cl)c1)c1ccccc1Oc1ccccc1 | [
"anti fungal"
] |
The molecule is a energy storage, energy source, nutrient, membrane stabilizer. | O=C1C(=O)N2CCc3cc4c(c5c3c2c1c1ccccc15)OCO4 | [
"Energy storage",
"Energy source",
"nutrient",
"Membrane stabilizer"
] |
The molecule is a nutrient. | CC/C=C\C/C=C\C/C=C\C/C=C\C=C/C(O)C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=C\C/C=C\C/C=C\CCCCCCCC | [
"nutrient"
] |
The molecule is a nutrient. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C=C\[C@H](O)CC | [
"nutrient"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts aging and tangier disease. | CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Aging",
"Tangier disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts tangier disease. The molecule is a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, barth syndrome, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, tangier disease, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Cholesterol translocation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Barth syndrome"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts barth syndrome, non-alcoholic fatty liver disease, and tangier disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Apoptosis",
"Aging",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts tangier disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Aging",
"Tangier disease",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase"
] |
The molecule is a nutrient. | CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C2=C(C)CCCC2(C)C)C(C)(C)CCC1 | [
"nutrient"
] |
The molecule is a renin inhibitor and belongs to the hypertension treatment class of molecules. | COC(=O)NCCCC(O)(c1cccc(Cl)c1Oc1ccccc1C)C1CCCN(C(=O)C2CCC(N)C2)C1 | [
"hypertension treatment",
"renin inhibitor"
] |
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, parkinson's disease, alzheimer's disease, and diabetes mellitus type 2. | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC)COP(=O)(O)OCCN | [
"Non-alcoholic fatty liver disease",
"Parkinson's disease",
"Alzheimer's Disease",
"Diabetes mellitus type 2",
"nutrient"
] |
The molecule is chemokine receptor modulator. | COC(=O)c1ccc(Cc2ccc(N)cc2)cc1 | [
"chemokine receptor modulator"
] |
It impacts cancer treatment. | CC(C)(O)CNC(=O)c1cc(-c2ccc(Cl)cc2)nc(-c2cccs2)n1 | [
"cancer treatment"
] |
The molecule is a emulsifier, energy storage, acaricide, membrane stabilizer and belongs to the pesticide class of molecules. The molecule is a energy source, nutrient, and surfactant, belonging to the anti mite class of molecules, and is both wood and herb. | CC1=C2CCC(C)C2CC(C(C)(C)O)CC1 | [
"Emulsifier",
"Energy storage",
"pesticide",
"acaricide",
"Membrane stabilizer",
"anti mite",
"Energy source",
"wood",
"nutrient",
"surfactant",
"herb"
] |
The molecule is a fat storage that impacts both metabolic syndrome and atherosclerosis. The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting both pancreatitis and cardiovascular disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COC(=O)CCCCCCC/C=C\CCCC | [
"Fat storage",
"Metabolic syndrome",
"Atherosclerosis",
"Pancreatitis",
"Thyroxine treatment",
"nutrient",
"Cardiovascular disease"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and aging. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Aging"
] |
The molecule is a air pollutant, sweet, coffee, and rooty. The molecule is a flavoring agent, food and nutrition, environmental contaminant, medicinal, and phenolic. | C=C(C)C(C)CCC(C)C1CCC2(C)C3CCC4C(C)C(O)CCC45CC35CCC12C | [
"sweet",
"coffee",
"Air pollutant",
"rooty",
"medicinal",
"phenolic",
"Flavoring agent",
"Food and nutrition",
"environmental contaminant"
] |
Hazardous decomposition products formed under fire conditions. - carbon oxides | C=C1C(O)C2OC3(CCC(C=CC(C)C4CC(C)=CC5(OC(CC(C)(O)C(=O)O)CCC5O)O4)O3)CCC2OC1C(O)CC(C)C1OC2(CCCCO2)CCC1C | [
"Decomposition_evaluation"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts barth syndrome, diabetic heart disease, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, aging, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing mitochondrial structure",
"Tangier disease"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts diabetic heart disease and aging. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC | [
"Cholesterol translocation",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Apoptosis",
"Aging",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a emulsifier, a stabilizing cytochrome oxidase, and a food additive, and it impacts diabetic heart disease. The molecule is a energy storage, membrane stabilizer, energy source, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a nutritional supplement, it impacts aging, and is smooth. The molecule is a apoptosis, surfactant, cholesterol translocation that impacts tangier disease and barth syndrome. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"Emulsifier",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"food additive",
"Non-alcoholic fatty liver disease",
"Energy storage",
"Membrane stabilizer",
"Energy source",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Smooth",
"Nutritional supplement",
"Aging",
"Apoptosis",
"Tangier disease",
"surfactant",
"Barth syndrome",
"Cholesterol translocation"
] |